In terms of the severity of NAFLD, the proportion of serious hepatic steatosis, elevated ALT and advanced fibrosis were 57.6%, 34.6% and 16.7%. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.